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Parodontologie/ Periodontology

CHAIRSIDE DIAGNOSTIC TEST KITS IN PERIODONTICS
- A REVIEW
Sachin Malagi*
Abstract
Traditionally, periodontal diseases have been diagnosed by radiographic and clinical exams, including the assessment of plaque
with a plaque index (PI), gingival inflammation with the bleeding on probing index (BOP), probing pocket depth (PPD) and clinical
attachment loss (CAL). Nowadays, clinical chairside tests are in use for more precise molecular diagnostics and treatments. This
review describes some diagnostic test kits on the market that can facilitate the clinical exams and the establishment of a diagnosis.
Keywords: Periodontal disease – gingival inflammation – diagnostic – chairside tests.
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KITS DE TEST DE DIAGNOSTIC EN PARODONTOLOGIE – UNE
REVUE DE LA LITÉRATURE
Résumé
Traditionnellement, les maladies parodontales sont diagnostiquées par des examens radiologiques et cliniques en utilisant certains
indices pour bien déterminer la sévérité et l’importance des atteintes : indice de plaque (IP), indice de saignement (IS), profondeur de
poche (PP) et niveau d’attachement (NA). Un inconvénient majeur de ces évaluations est leur incapacité de déterminer les phases
actives ou stables de la maladie parodontale. Actuellement, des tests cliniques peuvent être utilisés au cabinet dentaire pour des
diagnostics moléculaires plus précis permettant ainsi des diagnostics précoces et des traitements plus prompts. Ce papier est une
revue descriptive de quelques tests disponibles sur le marché dont l’usage facilite l’examen clinique et l’élaboration d’un diagnostic.
Mots-clés : maladie parodontale – inflammation gingivale – diagnostic.
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Introduction
Periodontitis is a prevalent disease of
men characterized by loss of connective tissue attachment and bone
around the teeth, in conjunction with
the formation of periodontal pockets
due to apical migration of the junctional epithelium. Periodontal disease
progression is episodic [1] and sitespecific [2].
More than 200 species of microorganisms colonize the oral cavity, but
only a few of these are thought to

be pathogens [3]. Among the subgingival bacterial species identified
so far, Porphyromonas gingivalis
(Pg), Prevotella intermedia (Pi) and
Aggregatibacter actinomycetemcomitans (Aa) have been associated with
progressive periodontitis [4]. Aa is
infrequently found in periodontally
healthy individuals [5], whereas Pi
has been found in either healthy subjects or patients with gingivitis [6].
Consequently, elevated levels of these
putative pathogens may be useful indicators of both active periodontitis and

increased risk of gingival attachment
loss. However, knowledge of how their
numbers relate to disease progression
is still unclear and for longitudinal
studies accurate assessment of their
numbers in clinical samples is needed.
The goal of periodontal diagnostic
procedures is to provide useful information to the clinician regarding the
present periodontal disease type,
location and severity. These findings
serve as a basis for treatment planning and provide essential data during
periodontal maintenance and disease
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monitoring phases. Traditional clinical
measurements (probing pocket depth,
bleeding on probing, clinical attachment loss, plaque index, radiographs)
used for periodontal diagnosis are
often of limited usefulness in that they
are indicators of previous periodontal
disease rather than present disease
activity.
The 1990s have seen the emergence of
a multitude of diagnostic tests based
on physical, chemical, microbiological
and immunological methodologies.
The philosophy behind the emergence
of such tests is that the earlier active
disease is diagnosed, the less invasive, time consuming, and therefore
costly the required treatment, and
the better the long term prognosis for
patients with destructive disease [7].
Furthermore, with the recognition that
risk groups and unpredictable disease
patterns exist, the benefits of objective
testing for initial diagnosis and for the
long-term maintenance of periodontal
patients become clear. For periodontal diagnosis, the ideal diagnostic test
should be [8]:
1. Quantitative.
2. Highly sensitive method capable of
analyzing a single periodontal site in
health as well as disease.
3. Reproducible.
4. Highly specific.
5. Simple to perform.
6. A rapid, one or two stage procedure.
7. Non-invasive.
8. Versatile in terms of sample handling, storage and transport.
9. Amendable to chairside use.
10. Economical.
11. Dependent upon simple and
robust
instrumentation.
Several
methods have been employed to
detect putative periodontopathogens
in clinical samples. These include
cultural methods, microscopy, immunofluorescent assays, enzyme-linked
immunosorbent assays, trypsin-like
protease assays, DNA probes [9] and
the PCR [10].
Among these tests, chairside periodontal kits provide immediate reports
of the microflora associated with the
disease compared to cumbersome and

Fig. 1: Omnigene.

Fig. 2: PerioScan®.

time-consuming traditional laboratory
procedures.
Chairside periodontal test kits can be
categorized as
•
Microbiological test kits
•
Biochemical test kits
•
Genetic kits

Microbiological test kits
The microbiological tests have the
potential to support the diagnosis of
various forms of periodontal disease,
to serve as indicators of disease initiation and progression and to determine
which periodontal sites are at higher
risk for active destruction. The bacteriological tests (Microscopy, Culture,
Omnigene, Affirm DP and Evalusite) are
mainly aimed at spirochetes, Aa, Pg and
Pi. Microbial tests can also be used to
monitor periodontal therapy directed
towards the suppression or eradication
of periodontopathogenic organisms.

Omnigene (Fig. 1)
These are DNA probe systems for a
number of known periodontopathogen subgingival bacteria. A paper
point sample of sub-gingival plaque is
placed in the container provided and
mailed off to the company for assay.
Probes are available for the detection
of A. actinomycetemcomitans, P. gingivalis, P. intermedia, F. nucleatum, C.
rectus, T. denticola and E. corrodens.
Reports are provided within very short
time periods (few hours to few days).

Evalusite
Evalusite is a kit that employs a novel
membrane-based enzyme immunoassay for the detection of three putative
periodontopathogens: Aa, Pg and Pi. A
sub-gingival sample is collected using
paper points and added to a sample
tube. The eluent is then added to the
kit, which employs a sandwich-type
ELISA (enzyme-linked immunosorbent
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assay); a pink spot is displayed if the
test organism is present. The main
weaknesses of this test kit reside in 1)
the assumption that the three detected organisms are causing disease;
(2) it is a multistage test; (3) it has a
subjective calorimetric end point and
(4) there is no permanent record of the
results [11].

PerioScan®
Perioscan is a diagnostic test kit that
utilizes the BANA (N-benzoyl-DLarginine-2-naphthylamide)-hydrolysis
reaction, developed to detect bacterial trypsin-like proteases in the dental plaque (Fig. 2). A trypsin-like activity has been identified in strains of P.
gingivalis, T. denticola, T. forsythia and
some Capnocytophagia strains [12,
13]. BANA is an example of a substrateconjugated beta-nepthylamine (p-NA),
which is hydrolyzed by this trypsin-like
enzyme to release free p-NA. The latter is a chromophore and reacts with a
variety of dyes (e.g. Fast-Garnet GBC)
to produce colored products.
Subgingival plaque is collected and
placed on a BANA-containing strip,
which is then folded to contact a
second strip containing the “FastBlack” dye reagent. The folded card
is placed inside an oven for 15 min
at 55°C and any blue-black color that
appears is scored positive for the above
species. The sensitivity of the method
has recently been improved [14]. The
main disadvantage of this technique
is that it relies upon plaque sampling
and assumes that the test organisms
identified as being present signify
active disease. This is known not to
be the case for all patients and sites.
Furthermore, results are qualitative
and rely upon the operator’s assessment of the calorimetric end point.
One of the potential difficulties of this
test is that it may be positive at clinically healthy sites and might remain so
after treatment.
The problem with all microbiological
tests is that it is likely that a range of
interacting bacteria is capable of causing disease, the combination may

differ between individuals, and tests
directed at individual species may be
too specific, and may not account for
different clonal types.

Biochemical test kits
Biochemical test kits used in periodontics analyze the gingival crevicular
fluid (GCF). Since this fluid is derived
from periodontal tissues, evaluating
its constituents such as host-derived
enzymes, inflammation mediators and
extracellular matrix components may
provide early signs of alterations.

Perio 2000
Various pathogenic microorganisms
like P. gingivalis, P. intermedia and T.
forsythia produce sulphates, thereby
significant levels of volatile sulphide
compounds (VSCs) by degradation of
serum proteins: cysteine and methionine. Since these VSCs can directly
degrade periodontal structures aggravating periodontitis, their evaluation
can indicate the subgingival microbial
load. Perio 2000 system is designed to
display the sulphide level digitally at
each site. In brief, the probe tip should
be hydrated using sterile wash solution provided by the manufacturer then
inserted subgingivally at peak or hold
operational mode. After a positive reading, the tip is washed and reinserted
in other subgingival site.

Prognos-Stik
This test kit was released in the year
1993. It detects elevated levels of
MMPs in the gingival crevicular fluid
such as the elastases. The GCF is collected onto the filter paper strip impregnated with a known amount of buffered elastase substrate labeled with a
fluorescent indicator. Elastase on the
test strip cleaves the substrate during
the reaction time of 4-6 minutes and
releases the indicator, visible under
fluorescent light. Elastase is released
from the lysosomes of polymorphonuclear leucocytes which accumulate
at sites of gingival inflammation. The
presence of elevated levels of elastase in GCF may thus be indicative of

active disease sites [15]. Although a
relationship between elastase levels in
GCF and periodontal disease activity
has been reported, the position is still
far from clear. Further clinical trials are
needed before the value of this test kit
in clinical practice can be ascertained.

Perio-Check
Periocheck has FDA (Food and Drug
Administration) approval in the United
States. It is reported to measure neutral
protease activity within GCF. The GCF
sample strip is placed on a gel containing insoluble dye-labelled collagen
fibrils (remazobrilliant blue-collagen
substrate powder) and incubated.
In the presence of neutral proteases
(which diffuse from the strip into the
gel), the insoluble collagen-dye complex is digested to release soluble dyelabelled fragments, which diffuse back
into the strip, turning it blue. Again the
test is only qualitative and not specific for PMNL collagenase, which is
thought to be the dominant collagenase at active sites [16]. Indeed, a high
proportion of the enzyme is likely to be
bacterial in origin. Furthermore, interproximal sites cannot be sampled, due
to the risk of saliva contamination, and
this is clearly a major drawback with
this method. It is the most rapid chairside test for neutral proteases in GCF
like elastases, proteinases and collagenases. The levels of these enzymes in
GCF have been noted to increase with
the development of gingivitis as well
as sites of established periodontitis.

PerioGard
PerioGard is based on the detection
of an enzyme called aspartate aminotransferase (AST). AST is a soluble
intracellular cytoplasmic enzyme that
is released from within the cell upon
its death. Since cell death is an important part of periodontal pathogenesis,
AST levels in GCF have great potential
as markers of early periodontal tissue
destruction. Elevated total AST levels
in a 30-second sample have been positively associated with disease-active
sites in contrast to inactive sites [17,
18]. This commercial test consists of a
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tray with two test wells for each tooth,
and appropriate reagent for conducting the test. The test involves collection of GCF with the filter paper strip
which is then placed in tromethamine
hydrochloride buffer. A substrate reaction mixture containing 1-aspartic and
α-keto-gluteric acid is added to the
sample and allowed to react for ten
minutes. In the presence of AST, the
Aspartate and α-keto-gluteric acid
are catalyzed to oxaloacetate and glutamate. The addition of a dye such
as fast red results in a color product,
the intensity of which is proportional
to the AST activity in the GCF sample
[19].
In practice, the PerioGard assay suffers from poor differentiation between
colors and is a relatively complex procedure involving multiple steps.

Pocket Watch
The Pocket Watch was developed as
a simple method of analyzing AST at
the chairside [20]. The principle of
this test is that, in the presence of
pyridoxal phosphate, AST catalyzes
the transfer of an amino group of
cysteine sulfuric acid by α- keto- gluteric acid to yield β-sulfinyl pyruvate.
Glutamate β-sulfinyl pyruvate spontaneously and rapidly decomposes and
releases inorganic sulfite. The sulfite
ion instantaneously reacts with malachite green (MG), simultaneously causing MG to convert from a green dye
to its colorless form, thereby allowing
the pink–colored rhodamine B dye to
show through. The rate of conversion
of MG is directly proportional to AST
concentration. However, components
of the extracellular matrix and its dissolved products are present in GCF
of destructive pockets, and they may
release sulfide ions. In brief, AST activity determined by Pocket Watch provides not only an index of cell death
but of the extent of the destructive
pockets.

initiation or progression of periodontal disease. In 1997, Kornman et al.
[21] found an association between the
polymorphism in the genes encoding
for interleukin-1α and interleukin-1β
and increased severity of periodontitis.
Identification of the genetic polymorphism is difficult but now some chairside kits are available for its detection.

PST® genetic susceptibility test
Periodontal susceptibility test (PST®)
is the first and only genetic test that
analyzes two interleukins (IL-1α and
IL-1β) genes for variations. IL-1 genetic
susceptibility may not initiate or cause
the disease but rather may lead to earlier or more severe disease. The IL-1
genetic test can be used to differentiate certain IL-1 genotypes associated
with varying inflammatory responses
to identify individuals at risk for severe
periodontal disease even before the
age of 60. Clinically, PST® is used in
[22]:
• New periodontal patients to assist in
developing treatment plans.
• Patients requiring extensive periodontal and/or implant therapy to
determine prognosis, improve patient
acceptance and optimize treatment
outcomes.
• Smoking patients as an additional
incentive for smoking cessation.
• Maintenance patients to set recall
intervals and improve compliance.
• Patients with early signs of disease to
help determine the need for referral to
a specialist.

Conclusion

Genetic test kits

In periodontology, the success of
any treatment is dependent upon
the accuracy of the initial diagnosis.
At present, the majority of chronic
periodontitis cases can be adequately
managed using existing diagnostic
methodology, although it is clearly
more desirable to be able to diagnose
“active disease” as it occurs, rather
than months later.

Various gene polymorphisms are
considered to be risk factors for the

Many of the biochemical chairside
diagnostic test kits have been marke-

ted. The newly commercially available
chairside tests for host and bacterial markers of periodontal disease
offer prospects which would make the
monitoring of specific sites possible.
However, the clinician must ensure
that the use of such tests will benefit
the patients in terms of both the value
of diagnostic data obtained and the
cost in time and money.
Validation of novel periodontal diagnostics need to be benchmarked
with existing gold standards of the
disease, such as alveolar bone levels
and clinical attachment levels, in large
populations.

103
Parodontologie / Periodontology

References
1. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck
JD, Offenbacher S. Potential for gingival crevice fluid markers
as predictors of risk for periodontal diseases. Periodontology
2000 2003,31:167–80.
2. Socransky S, Haffajee D, Goodson J, Lindhe J. New concepts of
destructive periodontal disease. J Clin Periodontol 1984;11:2132.
3. Loesche W. Chemotherapy of dental plaque infections. Oral Sci
Rev 1976;9:65-107.
4. Slots J, Bragd L, Wikstrom M, Dahlen G. The occurrence of
Actinobacillus actinomycetemcomitans, Bacteroides gingivalis
and Bacteroids intermedius in destructive periodontal disease
in adults. J Clin Periodontol 1986;13:570-577.
5. Sandmeier H, Van Winkelhoff AJ, Bar K, Ankli E, Maeder M,
Meyer J. Temperate bacteriophages are common among
Actinobacillus
actinomycetemcomitans
isolates
from
periodontal pockets. J Periodontol Res 1995;30:418-425.

15. Armitage G, Jeffcoat M, Chadwick D et al. Longitudinal
evaluation of elastase as a marker for the progression of
periodontitis. J Periodontol 1994;65; 120.
16. Chapple I, Matthews J, Thorpe G, Glenwright H, Smith J, Saxby
M. A new ultrasensitive chemiluminescent assay for the sitespecific quantification of alkaline phosphatase in gingival
crevicular fluid. J Periodont Res 1993;28:266-273.
17. Persson G, De Rouen T, Page R. Relationship between levels of
aspartate aminotransferase in gingival crevicular fluid and active
tissue destruction in treated chronic periodontitis patients. J
Periodont Res 1990;25:81-87.
18. Chambers D, Imrey P, Cohen R, Crawford J, Alves M, Mcswiggin
T. A longitudinal study of aspartate aminotransferase in human
gingival crevicular fluid. J Periodont Res 1991;26: 65-74.
19. Persson GR, Alves M, Chambers D, et al. A multicentered
clinical trial of PerioGard in distinguishing between diseased
and healthy periodontal sites. J Clin Periodontal 1995;22-7.

6. Christersson LA, Zambon J, Dunford R, Grossi, Genco R.
Specific subgingival bacteria and diagnosis of gingivitis and
periodontitis. J Dent Res 1989;68:1633-1639

20. Shimhadaka K, Mizuno T. Analysis of AST in gingival crevicular
fluid assessed using Perio Watch: A longitudinal study with
initial therapy. J Clin Periodontal 2000;27;819-23.

7. Kinane DF, 2000. Regulators of tissue destruction and
homeostasis as diagnostic aids in periodontology.
Periodontology 2000, 24: 215–225.

21. Kornman K, Crane A. The interleukin-1 genotype as a
severity factor in adult periodontal disease. J Clin Periodontal
1997;24;72-77.

8. Chapple I. Periodontal disease diagnosis: Current status and
future developments. J Dent 1997;25:3-15.

22. www.ilgenetics.com

9. Dahlin G. Role of suspected periodontopathogens in
microbiological monitoring of periodontitis. Adv Dent Res
1993;7:163-174.
10. Slots J, Ashimoto A, Flynn MJ, Li G, Chen C. Detection of
putative periodontal pathogens in subgingival specimens by
16S ribosomal DNA amplification with the polymerase chain
reaction. Clin Infect Dis 1995;20:S304-S307.
11. Mikx FH, Renggli HH. How sensible are bacteriological
tests in periodontology? Ned Tijdschr Tandheelkd. 1994
Dec;101(12):484-8.
12. Laughton B, Syned S, Loesche W. API ZYM system for
identification of Bacteroides ssp., Capnocytophagia ssp., and
spirochaetes of oral origin. J Clin Microbial 1982;15:97-127.
13. Loesche W, Syed S, Stoll J. Trypsin-like activity in sub-gingival
plaque: A diagnostic marker for spirochetes and periodontal
disease? J Periodont 1987;58:266-273.
14. Ishihara K, Naito Y, Kato T, Takazoe I, Okuda K, Eguchi T,
NakashimaK , Matsuda M, Yamasaki K, HasegawaK , Suido
H, Sugihara K. A sensitive enzymatic method (SK- 013) for
detection and quantification of specific periodontopathogens.
J Periodont Res 1992; 27: 81-85.

